Clinical Research Studies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Osteoarthritis
• Age: Between 18 years - 90 years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1. Subject needing primary TKA due to degenerative joint disease (primary diagnosis of osteoarthritis), post-traumatic arthritis or inflammatory arthritis OR
  2. Subject has undergone primary TKA with Smith+Nephew Porous knee system in past 12 months to repair degenerative joint disease, post traumatic arthritis or inflammatory arthritis and all the following conditions have been met:
     • Preoperative KOOS JR and radiographs have been obtained
     • 6-Month KOOS JR and radiographs have been obtained or these can be collected prospectively in window per schedule of events
     • 12-Month KOOS JR and radiographs have been obtained or these can be collected prospectively in window per schedule of events
  3. Subject agrees to consent and to follow the prospective study visit schedule
  4. Subject is willing to attend study follow-up visits for up to ten (10) years post-surgery
  5. Subject is able to read, understand, and communicate responses to Patient Reported Outcome assessments

  
  

You may not be eligible for this study if the following are true:

• 1. Subject received TKA on the contralateral knee as a revision for a previously failed total or unicondylar knee arthroplasty
  2. Subject has a Body Mass Index (BMI) >= 40 at time of surgery
  3. Subject has ipsilateral hip arthritis resulting in flexion contracture.
  4. At the time of enrolment, subject has one or more of the following arthroplasties that are not fully healed and well-functioning, as determined by the investigator: Ipsilateral or contralateral primary total hip arthroplasty or hip resurfacing arthroplasty; Contralateral primary total knee or unicondylar knee arthroplasty
  5. Subject has a condition that may interfere with the TKA survival or outcome
  6. Subject has a known allergy to one or more of its components of the study device
  7. Any subject with hardware present in distal femur or proximal tibia
  8. Subject is entered in another drug, biologic, or device study or has been treated with an investigational product in the past 30 days
  9. Subject, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, drug or alcohol abuse
  10. Subject is known to be at risk for lost to follow-up, or failure to return for scheduled visits
  11. Women who are pregnant, nursing, or of child-bearing potential who are not utilizing highly effective birth control measures
  12. Subjects who have participated previously in this clinical trial and who have been withdrawn